About Us
Mission & Vision
Company
Leadership
Center of Biological Technology and Innovation (CBTI)
Quality & Compliance
IP Protection
Milestones & Awards
ESG
Services & Solutions
Developability Assessment
Antibodies & Recombinant Biotherapeutics
Bioconjugates
mRNA
Analytical Science & Quality Control
Regulatory Affairs
Join Us
Job Opportunity
Talent Development
Investors
News & Resources
Company News
Events
Knowledge Center
Contact Us
Address
Asymchem Boston Corporation 10 Gill Street, Suite J Woburn, MA 01801
Phone
E-mail
MKT@asymchem.com.cn
Home
About Us
Mission & Vision
Company
Leadership
Center of Biological Technology and Innovation (CBTI)
Quality & Compliance
IP Protection
Milestones & Awards
ESG
Services & Solutions
Developability Assessment
Antibodies & Recombinant Biotherapeutics
Cell Line Construction & Development
Upstream Process Development
Downstream Process Development
Drug Product (DP) Development
Drug Substance (DS) Manufacturing
Drug Product (DP) Manufacturing
Antibodies & Recombinant Biotherapeutics Release Testing
Bioconjugates
Payload-Linker CMC Services
Antibody Intermediate Manufacturing
Bioconjugates Process Development
Drug Product Development
Drug Substance Manufacturing
Drug Product Manufacturing
Bioconjugates Release Testing
mRNA
Plasmid Linearization Process Development
In Vitro mRNA Transcription Process Development
mRNA-LNP Process Development
mRNA Production
mRNA Release Testing
Analytical Science & Quality Control
Physicochemical Analysis of Recombinant Biotherapeutics & Bioconjugates
Mass Spectrometry Analysis
Bioassay
Release Testing
Stability Studies
Regulatory Affairs
Join Us
Job Opportunity
Talent Development
Investors
News & Resources
Company News
Events
Knowledge Center
Publication & Case Study
Poster
Brochure
Video
Webinar
Contact Us
CN
Publication & Case Study
Company News
Events
Knowledge Center
Knowledge Center
Publication & Case Study
Poster
Brochure
Video
Webinar
Building Adaptive Conjugation Process Development Strategies for Novel Bioconjugate Modalities
Removal of Aggregates During Bispecific Antibody Purification Using Hydrophobic Interaction Chromatography
Application of the design of experiment to characterize depth filtration for bispecific antibody clarification
Development of Versatile and Scalable Bioconjugation Processes for Next-Generation ADCs
Developing Robust and Scalable Processes to Expedite the Development and Manufacturing of ADCs
Developing Robust and Scalable BioconjugationProcesses for Accelerated ADC Development and Manufacturing
Measuring Site Occupancy and Site specific Drug Distribution of Cysteine Conjugated ADCs by a LC MS/MS Approach
Dual formation mechanisms of acidic variants in cysteine-engineered antibodies and strategies for their reduction
Prev
1
Next
MKT@asymchem.com.cn
